Infectious Disease · HIV-Associated Neurocognitive Disorder

The Biology of HIV and Ruling Out Other Causes

At a Glance

Memory and thinking changes in a person with HIV are not always caused by HIV itself. Depression, health conditions, medicines, alcohol or cannabis, vitamin or thyroid problems, and serious infections can contribute, so clinicians investigate the picture and use an MRI or spinal tap when needed.

Understanding why HIV affects the brain requires looking at the “invisible” activity of the virus and the many other factors that can influence how you think and feel. Cognitive changes in people living with HIV are rarely caused by just one thing; instead, they are usually multifactorial, meaning many different health issues are working together ^[1]^[2].

How HIV Interacts with the Brain

Even when antiretroviral therapy (ART) is working perfectly and your blood tests show an “undetectable” viral load, the virus can still have a footprint in the nervous system.

The Viral “Reservoir”: HIV enters the central nervous system very early after infection. It can “hide” in specialized brain cells called microglia and macrophages ^[3]^[4]. These cells can act as a reservoir where the virus remains even when it is suppressed to undetectable levels in the blood. (Note: Having a reservoir does not automatically mean the virus is actively damaging your brain today.)
Chronic Inflammation: The presence of the virus, or past damage, can keep the brain’s immune system in a state of constant “high alert.” This neuroinflammation can affect the connections between brain cells over time, which may contribute to HAND ^[5]^[6].
CSF Viral Escape: In uncommon cases, the HIV virus can be detectable in the cerebrospinal fluid (CSF) (the fluid surrounding your brain and spine) even when it is undetectable in the blood ^[7]^[8]. This “escape” is an uncommon, specialist diagnosis, not the default explanation for most cognitive symptoms ^[9].

Ruling Out Other “Masks”

Because many different conditions look like HAND, your doctor must play the role of a detective. They need to ensure your symptoms aren’t being worsened by other treatable issues:

Mental Health: Depression and anxiety can produce genuine, mood-related cognitive symptoms. This does not mean your symptoms are “fake”; depression and HAND can easily occur together ^[10]^[11]. Treating the mood disorder is an important part of the evaluation and may improve your clarity.
Metabolic and Vascular Health: Conditions like type 2 diabetes, high blood pressure, and high cholesterol can damage small blood vessels in the brain, leading to cognitive decline ^[12]^[13].
Medication and Substance Effects: Some medications (especially sedating or anticholinergic drugs), as well as alcohol or cannabis use, can slow down your thinking or affect your focus ^[14]^[15].
Nutritional Deficiencies: Low levels of Vitamin B12 or issues with the thyroid gland can mimic the symptoms of HAND and are easily treated ^[16]^[17].

Ruling Out Serious Infections

If your cognitive symptoms are worsening quickly, your doctor must rule out opportunistic infections. These are serious illnesses that typically only occur when the immune system is significantly weakened (usually when CD4 counts are very low):

PML (Progressive Multifocal Leukoencephalopathy): A viral infection that attacks the white matter of the brain, causing rapid weakness or speech changes ^[18]^[17].
Toxoplasmosis: A parasite that can cause “lesions” or spots on the brain, often leading to confusion or headaches ^[18].
Cryptococcal Meningitis: A fungal infection of the lining of the brain that causes severe headaches, fever, and confusion ^[19]^[20].

To rule these out, your care team may use an MRI to look at the structure of your brain or a lumbar puncture (spinal tap) to check the CSF for signs of infection ^[21]^[22]. These tests are considered selectively for new, progressive, or unexplained symptoms, not for everyone with mild forgetfulness. Identifying the true cause of your symptoms is the first step toward the right treatment.

Common questions in this guide

Can HIV affect the brain when my blood viral load is undetectable?

Yes. HIV can enter the central nervous system early and remain in immune cells in the brain, and in uncommon cases it can be detected in the fluid around the brain and spinal cord even when blood tests are undetectable. A viral reservoir alone does not prove that HIV is actively damaging the brain.

What other conditions can cause memory problems or brain fog with HIV?

Depression or anxiety, diabetes, high blood pressure, high cholesterol, sedating or anticholinergic medicines, alcohol or cannabis, vitamin B12 deficiency, and thyroid problems can affect thinking. These factors may occur alongside HIV-associated neurocognitive disorder, so clinicians review the full picture rather than assuming one cause.

When would I need an MRI or a spinal tap for HIV-related cognitive symptoms?

Doctors may consider an MRI or lumbar puncture when symptoms are new, worsening, rapidly progressive, or otherwise unexplained, especially when a serious infection is possible. These tests are not routinely needed for everyone with mild forgetfulness.

Which warning signs could point to a serious brain infection?

Rapidly worsening confusion or thinking problems, sudden weakness, speech changes, trouble with balance, a stiff neck, severe headache, or fever should be reported promptly. In people with major immune suppression, clinicians may evaluate for infections such as PML, toxoplasmosis, or cryptococcal meningitis.

Can depression or anxiety be the reason for my brain fog?

Yes. Depression and anxiety can cause real problems with concentration and thinking, and they can also occur at the same time as HIV-associated neurocognitive disorder. Evaluating and treating a mood condition may improve mental clarity but does not replace assessment for other causes.

Could my medicines, alcohol, or cannabis be affecting my thinking?

Yes. Some medicines, especially sedating or anticholinergic drugs, and alcohol or cannabis can slow thinking or reduce focus. Ask your clinician to review your medicines and substance use before making changes to prescribed treatment.

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Dementia associated with AIDS.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Curated prompts to bring to your next appointment.

1.Since my viral load is undetectable in my blood, is it possible the virus is still active in my spinal fluid?
2.How can we determine if my memory issues are caused by HIV or by my other health conditions, like diabetes or high blood pressure?
3.Could the depression or anxiety I'm feeling be a main contributor to my 'brain fog' rather than the virus itself?
4.Do I need an MRI or a lumbar puncture (spinal tap) to rule out other serious infections?
5.Are any of my current medications—HIV-related or otherwise—known to cause cognitive side effects?

Key takeaways

HIV can enter the brain early and persist in immune cells even when the blood viral load is undetectable, but a viral reservoir does not automatically mean active brain damage.
Cognitive symptoms in people with HIV are often multifactorial and may also be linked to depression, diabetes, blood vessel risk factors, medications, substances, vitamin B12 deficiency, or thyroid problems.
Rapidly worsening symptoms or signs such as weakness, speech changes, severe headache, fever, stiff neck, or balance problems require prompt evaluation for serious infections.
An MRI or lumbar puncture may be used selectively when symptoms are new, progressive, or unexplained; these tests are not needed for everyone with mild forgetfulness.
Reviewing the full medical history and treating contributing conditions helps guide the right care.

References (22)

1
Neuropathogenesis of human immunodeficiency virus infection.
Sillman B, Woldstad C, Mcmillan J, Gendelman HE
Handbook of clinical neurology 2018; (152()):21-40 doi:10.1016/B978-0-444-63849-6.00003-7.
PMID: 29604978
2
Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.
Rosenthal J, Tyor W
Journal of neurovirology 2019; (25(5)):673-685 doi:10.1007/s13365-019-00735-0.
PMID: 30868422
3
Neuropathogenesis of acute HIV: mechanisms, biomarkers, and therapeutic approaches.
Jia FF, Brew BJ
Current opinion in HIV and AIDS 2025; (20(3)):199-208 doi:10.1097/COH.0000000000000923.
PMID: 40110851
4
The brain as an HIV reservoir: Recent findings using autopsy tissues from people with HIV.
Dave RS, Oludipe AA, Pasipanodya EC, et al.
PLoS pathogens 2026; (22(7)):e1014446 doi:10.1371/journal.ppat.1014446.
PMID: 42525639
5
Mechanisms of CNS Viral Seeding by HIV+ CD14+ CD16+ Monocytes: Establishment and Reseeding of Viral Reservoirs Contributing to HIV-Associated Neurocognitive Disorders.
Veenstra M, León-Rivera R, Li M, et al.
mBio 2017; (8(5)) doi:10.1128/mBio.01280-17.
PMID: 29066542
6
HIV-1 Tat and gp120 as key drivers of neurodegeneration in the central nervous system.
Cecchetto R, Diani E, Lotti V, et al.
Frontiers in microbiology 2026; (17()):1895162 doi:10.3389/fmicb.2026.1895162.
PMID: 42656799
7
CSF Inflammation Markers Associated with Asymptomatic Viral Escape in Cerebrospinal Fluid of HIV-Positive Individuals on Antiretroviral Therapy.
Guha D, Misra V, Yin J, Gabuzda D
Viruses 2023; (15(9)) doi:10.3390/v15091829.
PMID: 37766236
8
Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV.
Trunfio M, Rugge W, Mighetto L, et al.
AIDS (London, England) 2020; (34(13)):1899-1906 doi:10.1097/QAD.0000000000002601.
PMID: 32701580
9
Brain health in HIV: pathogenesis, classification, and treatment.
Holroyd KB, Winston A, Nightingale S
Current opinion in neurology 2025; (38(4)):373-379 doi:10.1097/WCO.0000000000001390.
PMID: 40466022
10
Self-Reported Decline in Everyday Function, Cognitive Symptoms, and Cognitive Function in People With HIV.
Laverick R, Haddow L, Daskalopoulou M, et al.
Journal of acquired immune deficiency syndromes (1999) 2017; (76(3)):e74-e83 doi:10.1097/QAI.0000000000001468.
PMID: 29016449
11
Multimodal Approach to Neurocognitive Function in People Living with HIV in the cART Era: A Comprehensive Review.
Moschopoulos CD, Stanitsa E, Protopapas K, et al.
Life (Basel, Switzerland) 2024; (14(4)) doi:10.3390/life14040508.
PMID: 38672778
12
HIV, Vascular Risk Factors, and Cognition in the Combination Antiretroviral Therapy Era: A Systematic Review and Meta-Analysis.
McIntosh EC, Tureson K, Rotblatt LJ, et al.
Journal of the International Neuropsychological Society : JINS 2021; (27(4)):365-381 doi:10.1017/S1355617720001022.
PMID: 33161930
13
Metabolic Syndrome and Cardiovascular Disease Impacts on the Pathophysiology and Phenotype of HIV-Associated Neurocognitive Disorders.
Moulignier A, Costagliola D
Current topics in behavioral neurosciences 2021; (50()):367-399 doi:10.1007/7854_2019_123.
PMID: 31989463
14
Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy.
Schouten J, Su T, Wit FW, et al.
AIDS (London, England) 2016; (30(7)):1027-38 doi:10.1097/QAD.0000000000001017.
PMID: 26752277
15
CNS Neurotoxicity of Antiretrovirals.
Lanman T, Letendre S, Ma Q, et al.
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2021; (16(1)):130-143 doi:10.1007/s11481-019-09886-7.
PMID: 31823251
16
HIV-associated neurocognitive disorder and HIV-associated myelopathy in a patient with a preserved CD4, but high viral load-a rarely reported phenomenon: a case report and literature review.
Ayele BA, Amogne W, Gemechu L
BMC infectious diseases 2020; (20(1)):574 doi:10.1186/s12879-020-05297-9.
PMID: 32758161
17
Ethical and Clinical Considerations in the Workup of HIV-Associated Neurocognitive Decline.
Davis K, Grant KG, Sousou JM, Ilechukwu S
Cureus 2025; (17(11)):e97348 doi:10.7759/cureus.97348.
PMID: 41426939
18
Revisiting the Intracranial Neurological Imaging Manifestations of Human Immunodeficiency Virus: Pictorial Review with a Pattern-Based Approach.
Mehra S, Verma D, Bansal L
The Indian journal of radiology & imaging 2026; (36(2)):274-282 doi:10.1055/s-0045-1811238.
PMID: 41867294
19
Neurologic Complications of Human Immunodeficiency Virus Infection.
Saylor D
Continuum (Minneapolis, Minn.) 2018; (24(5, Neuroinfectious Disease)):1397-1421 doi:10.1212/CON.0000000000000647.
PMID: 30273245
20
Global developments in HIV neurology.
Wright EJ, Thakur KT, Bearden D, Birbeck GL
Handbook of clinical neurology 2018; (152()):265-287 doi:10.1016/B978-0-444-63849-6.00019-0.
PMID: 29604981
21
Managing cognitive impairment in people with HIV.
Alford K, O'Brien C, Banerjee S, et al.
Current opinion in infectious diseases 2025; (38(1)):1-9 doi:10.1097/QCO.0000000000001078.
PMID: 39602088
22
One for all, all for one: neuro-HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV.
Damas J, Darling KEA, Bidlingmeyer P, et al.
HIV medicine 2023; (24(6)):738-748 doi:10.1111/hiv.13472.
PMID: 36890672

This page is for informational purposes only and does not constitute medical advice. It explains how clinicians evaluate HIV-related cognitive changes; discuss symptoms, tests, and treatment with your HIV care team.

Guide Contents